Biogen’s Tau Antibody Fails In PSP, But Alzheimer’s Studies Continue

 
• By Mandy Jackson
  
Diagnosis Progressive Supranuclear Palsy, pills and stethoscope.
Gosuranemab is at least the second anti-tau agent to fail in PSP this year. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D